Trial Details
UNKNOWNBasic Information
| Clinical ID | c363 |
|---|---|
| Identifier | NCT02335281 |
| Trial Title | Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease|Ulcerative Colitis|Crohn's Disease |
| Interventions | PROCEDURE: FMT|DRUG: Mesalazine |
Participant Information
| Sponsor | Yanling Wei |
|---|---|
| City | Chongqing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-01-15 |
|---|---|
| Primary Completion Date | 2025-10-17 |
| Completion Date | 2025-12-17 |